PixarBio Corporation has announced an agreement with Particle Sciences to cGMP manufacture PixarBio’s NR14 product for clinical trials. NeuroRelease NR14 is a 14 day morphine replacement, and non-addictive pain platform for post-surgical pain.   In 2018, PixarBio will be able to apply to the US FDA for fast track approval through the CDER Breakthrough Therapy designation.   “Although the agreement covers our 14 day treatment, we also have a 7 and 3 day product in our pipeline tha...